← Leaderboards
Bruce S Sachais
University Of Pennsylvania
$5,100,172
Attributed
$5,100,172
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $980K · FY2006–17$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,100,172 · 5
By mechanism
R01$2,105,660 · 1
R42$1,942,140 · 1
K08$656,235 · 1
R41$396,137 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Christos Coutifaris$14,929,974
- Junhyong Kim$20,435,061
- Kathleen Elise O'Neill$943,719
- David A Mankoff$17,196,499
- Boris Striepen$21,753,911
Others in their field
Top investigators on “Platelet Factor 4”
- Mortimer Poncz · University Of Pennsylvania$33,265,241
- Alan R. Shuldiner · University Of Maryland Baltimore$17,767,642
- S. Claiborne Johnston · University Of California San Francisco$17,733,443
- Joel S. Bennett · University Of Pennsylvania$13,681,200
- Yuko Y Palesch · Medical University Of South Carolina$13,356,359
- Edward Franklin Plow · Cleveland Clinic Foundation$12,758,347
Research focus
Platelet Factor 4DesignAtherosclerosisProgramsPropertyBaseBlood PlateletsLow Density Lipoprotein ReceptorPlatelet ActivationApplications GrantsApolipoproteinsReceptor BindingUnited States National Institutes Of HealthUniversitiesMorbidity - Disease RateMeetingsHealth TrainingHuman SubjectGenetically Modified AnimalsGrantInstitutionBehavioral/Social ScienceBlood VesselsEducational Aspects
Grant awards (15)
SMALL MOLECULE ANTAGONISTS OF PF4 FOR THE TREATMENT AND PREVENTION OF HIT$962,140
R42 · FY2017 · HL · contact PI
SMALL MOLECULE ANTAGONISTS OF PF4 FOR THE TREATMENT AND PREVENTION OF HIT$980,000
R42 · FY2016 · HL · contact PI
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT$225,000
R41 · FY2014 · HL · contact PI
Proatherogenic properties of platelet fator 4$384,759
R01 · FY2010 · HL · contact PI
Proatherogenic properties of platelet fator 4$384,759
R01 · FY2009 · HL · contact PI
Proatherogenic properties of platelet fator 4$170,374
R01 · FY2009 · HL · contact PI
Proatherogenic properties of platelet fator 4$384,759
R01 · FY2008 · HL · contact PI
Proatherogenic properties of platelet factor 4$384,759
R01 · FY2007 · HL · contact PI
Proatherogenic properties of platelet factor 4$396,250
R01 · FY2006 · HL · contact PI
Drugs targeting intact lipoprotein receptors$171,137
R41 · FY2004 · HL
EFFECT OF PF4 ON LIPOPROTEIN METABOLISM/ATHEROSCLEROSIS$131,247
K08 · FY2004 · HL
EFFECT OF PF4 ON LIPOPROTEIN METABOLISM/ATHEROSCLEROSIS$131,247
K08 · FY2003 · HL
EFFECT OF PF4 ON LIPOPROTEIN METABOLISM/ATHEROSCLEROSIS$131,247
K08 · FY2002 · HL
EFFECT OF PF4 ON LIPOPROTEIN METABOLISM/ATHEROSCLEROSIS$131,247
K08 · FY2001 · HL
EFFECT OF PF4 ON LIPOPROTEIN METABOLISM/ATHEROSCLEROSIS$131,247
K08 · FY2000 · HL